Clinical Trial Update: Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluates the safety and efficacy of aprepitant for chemotherapy-induced nausea and vomiting in patients with lung cancer receiving …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Aprepitant (aprepitant)

Snippet

Sponsor: Zhejiang University | Conditions: Chemotherapy-Induced Nausea and Vomiting, Lung Cancer | Phase 2 | Status: UNKNOWN